Fundz

Nanoviricides, Inc. reported raising $2.5 Million in an initial SEC Form D filing, from an offering of $2.5 Million

PUBLIC · NNVCMar 08, 2019

Amount Raised

$2.5 Million

$2.5 Million sold, per SEC Form D (first sale Mar 8, 2019)

Round Type

Seed

SheltonBiotechnologyHealthcareHealth Care

Quick answer

Nanoviricides raised $2.5 Million in a Seed round, dated March 8, 2019. Nanoviricides is based in Shelton, Connecticut, United States.

How much did Nanoviricides raise?
Nanoviricides raised $2.5 Million in a Seed round on March 8, 2019.
What does Nanoviricides do?
Nanoviricides, Inc. is a biotechnology company focused on developing proprietary nanomedicine technologies for the treatment of viral infections.
Where is Nanoviricides based and how big is it?
Nanoviricides is based in Shelton, Connecticut, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Nanoviricides that raised within 45 days of this round, from Fundz verified event records.

  • Korsana Biosciences raised $175M on April 17, 2019.
  • valisure llc raised $853K (Seed) on April 10, 2019.
  • Adagio Medical raised $7M on April 8, 2019.
  • Citius Pharmaceuticals, Inc. raised $429K (Seed) on April 8, 2019.
  • CytoDyn raised $3.2M (Seed) on April 2, 2019.
  • ViaLase raised $8.1M on April 2, 2019.

Who to call at Nanoviricides, and when

A new round usually means Nanoviricides is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nanoviricides raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nanoviricides, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nanoviricides. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nanoviricides

Location

Shelton, Connecticut, United States

About

Nanoviricides, Inc. is a biotechnology company focused on developing proprietary nanomedicine technologies for the treatment of viral infections. The company primarily targets the development of antiviral agents and therapies through its unique nanoviricide platform, which is designed to specifically approach virus treatment at a molecular level. With key developments in therapeutic agents for various viral diseases, Nanoviricides aims to address significant unmet medical needs. Operating out of Shelton, Connecticut, the company is involved in cutting-edge research and strategic collaborations to advance its innovative products in the pharmaceutical and healthcare sectors. The company maintains a focus on emerging markets in virology and aims to expand its reach in the biopharmaceutical industry.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nanoviricides raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Nanoviricides's next move

See what Strategic adds

Nanoviricides raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.